Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-23 4:49 pm Unchanged |
2024-12-19 | 13D | TechPrecision Corporation TPCS |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 433,605 4.500% |
0 (Unchanged) |
Filing History |
| 2024-07-30 08:30 am Unchanged |
2024-07-30 | 13D | TechPrecision Corporation TPCS |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 433,605 4.800% |
0 (Unchanged) |
Filing History |
| 2024-07-05 2:17 pm Purchase |
2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% |
80,871 (+1.64%) |
Filing History |
| 2024-07-02 4:54 pm Purchase |
2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% |
5,007,666 (New Position) |
Filing History |
| 2024-07-02 4:32 pm Purchase |
2024-07-02 | 13D | TechPrecision Corporation TPCS |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 433,605 4.800% |
433,605 (New Position) |
Filing History |
| 2023-03-16 4:15 pm Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,926,795 16.600% |
464,285 (+10.40%) |
Filing History |
| 2023-02-16 4:43 pm Purchase |
2023-02-07 | 13G | S&W Seed Company SANW |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 216,471 9.700% |
216,471 (New Position) |
Filing History |
| 2022-12-02 4:15 pm Purchase |
2022-11-25 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,462,510 14.800% |
884,805 (+24.73%) |
Filing History |
| 2022-03-22 4:15 pm Purchase |
2022-03-16 | 13D | Summer Infant, Inc. SUMR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 784,183 36.200% |
25,396 (+3.35%) |
Filing History |
| 2022-01-20 4:16 pm Purchase |
2022-01-12 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,577,705 12.100% |
387,400 (+12.14%) |
Filing History |
| 2021-04-20 4:15 pm Purchase |
2021-04-12 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,190,305 10.900% |
507,905 (+18.93%) |
Filing History |
| 2020-11-03 4:23 pm Purchase |
2020-11-03 | 13D | MusclePharm Corporation MSLP |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,111,874 6.400% |
100,000 (+4.97%) |
Filing History |
| 2020-10-28 3:57 pm Sale |
2020-10-26 | 13D | MusclePharm Corporation MSLP |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,874 6.100% |
-31 (-0.00%) |
Filing History |
| 2020-08-14 5:14 pm Purchase |
2020-08-10 | 13D | MVC CAPITAL, INC. MVC |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,559,270 8.800% |
44,891 (+2.96%) |
Filing History |
| 2020-07-13 2:07 pm Purchase |
2020-07-13 | 13D | MusclePharm Corporation MSLP |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,905 6.200% |
80,600 (+4.17%) |
Filing History |
| 2020-06-01 4:30 pm Unchanged |
2020-05-27 | 13D | MVC CAPITAL, INC. MVC |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.500% |
0 (Unchanged) |
Filing History |
| 2020-04-27 4:47 pm Unchanged |
2020-04-24 | 13D | MVC CAPITAL, INC. MVC |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.500% |
0 (Unchanged) |
Filing History |